Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Debt / NOTE 2.500% 2/1
-
Number of holders
-
13
-
Total 13F principal, excl. options
-
38,174,000
-
Principal change
-
-156,384,000
-
Total reported value, excl. options
-
$39,681,566
-
Value change
-
-$170,888,151
-
Number of buys
-
7
-
Number of sells
-
-23
-
Price
-
$1.04
Significant Holders of AMAG PHARMACEUTICALS INC - NOTE 2.500% 2/1 as of Q2 2017
34 filings reported holding 00163UAA4 - AMAG PHARMACEUTICALS INC - NOTE 2.500% 2/1 as of Q2 2017.
AMAG PHARMACEUTICALS INC - NOTE 2.500% 2/1 has 13 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $38,174,000 of principal
.
Largest 10 bondholders include TENOR CAPITAL MANAGEMENT Co., L.P. ($9,291,000 of principal), Birch Grove Capital LP ($7,424,000 of principal), Bruce & Co., Inc. ($5,500,000 of principal), FMR LLC ($5,100,000 of principal), JPMORGAN CHASE & CO ($4,365,000 of principal), CSS LLC/IL ($3,305,000 of principal), SONORA INVESTMENT MANAGEMENT, LLC ($1,430,000 of principal), Iron Financial, LLC ($1,025,000 of principal), Allianz Asset Management GmbH ($700,000 of principal), and MORGAN STANLEY ($26,000 of principal).
This table shows the top 13 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.